Clinical trials
Phase 2 Lymphedema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 4 |
| Terminated | 3 |
| Unknown status | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| National Center for Complementary and Integrative Health (NCCIH) | 2 |
| Alice Chung | 1 |
| Columbia University | 1 |
| Eiger BioPharmaceuticals | 1 |
| Gynecologic Oncology Group | 1 |
| Herantis Pharma Plc. | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Kathy Miller | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphedema | 24 |
| Breast Neoplasms | 7 |
| Fibrosis | 3 |
| Postoperative Complications | 2 |
| Radiation Fibrosis Syndrome | 2 |
| Radiation Injuries | 2 |
| Breast Cancer Lymphedema | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.